Health Condition 1: null- Patients with all forms of Ekkustha(Psoriasis)With Classical Signs Symptoms of Ekkustha(Psoriasis) age limit above 18 years to below 60 years Health Condition 2: L409- Psoriasis, unspecified Health Condition 3: L409- Psoriasis, unspecified
Conditions
Interventions
Intervention1: Guduchi Ghrita prepared with Kwatha: orally -10 Gm BD with luke warm water(for 2 months)
for local application- as per quantity sufficient
(for 2 months)
Control Intervention1: Guduchi
Sponsors
Ipgt and Ra
Eligibility
Inclusion criteria
Inclusion criteria: PATIENTS WITH ALL FORMS OF EKKUSTHS(PSORIASIS) WITH CLASSICAL SIGNS AND SYMTOMS OF EKKUSTHA(PSORIASIS) >18 YEARS to <60 YEARS
Exclusion criteria
Exclusion criteria: 60 YEARS
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| By providing better effect in general psoriasis disordre,the drug will effect psychosomatic level of the enrolled patients, enhance quality of life and will contribute in reducing disability adjusted life year.Over all improvement in the disease condition, quality of life diseased. overall improvment in the disease condition. BASED ON THE OBSERVATION.Timepoint: 12 weeks | — |
Primary
| Measure | Time frame |
|---|---|
| IT IS EXPECTED THAT TRIAL DRUG WILL EXERT A SIGNIFICANT ACTION ON SIGNS AND SYMTOMS OF PSORIASIS .Timepoint: IT IS EXPECTED THAT TRIAL DRUG WILL EXERT A SIGNIFICANT ACTION ON SIGNS AND SYMTOMS OF PSORIASIS in 2 months period time. | — |
Countries
India
Contacts
Public ContactJigisha patel
Guide
Outcome results
None listed